Company / Operating Margin
UroGen Pharma Ltd. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-113.7%
FY2025
5-year range
-192.1% / -113.7%
FY2021-FY2025
Trend
+33.5%
vs FY2024
Sector context
#88 of 136
Health Care
What the data says
At -113.7%, UroGen Pharma Ltd.'s operating margin ranks #88 of 136 in the Health Care sector. Operating Margin has fluctuated over the past 9 years, ranging from -608211.1% in FY2020 to 4.6% in FY2016.
Based on SEC 10-K filings.
-113.7% in FY2025 with a 5-year CAGR of +608097.4%.
Improved from -122.8% to -113.7% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +78.4pp
- 5-Year Change
- +608097.4pp
- 10-Year Change
- -
Sector benchmark
#88 of 136 in Health CareTop 65% of 136This company -113.7% Sector average -778.9%
▼
+85.4% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 33.5% year-over-year.
- Currently 665.2pp above the Health Care sector average.
- Peak operating margin was recorded in FY2016.
- Lowest operating margin in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.09 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -113.7% | +33.5% |
| FY2024 | -171.0% | -39.2% |
| FY2023 | -122.8% | +36.1% |
| FY2022 | -192.1% | +0.0% |
| FY2021 | -192.1% | +100.0% |
| FY2020 | -608211.1% | -248606.2% |
| FY2019 | -244.6% | +96.4% |
| FY2018 | -6842.2% | - |
| FY2017 | - | - |
| FY2016 | 4.6% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026